Manuel Wieser

Manuel Wieser serves as Chief Technology Officer at AnteoTech. AnteoTech operates in the biotechnology sector with approximately 34.0 employees. AnteoTech generates annual revenue of 203000.0.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • We have verified contacts for 2 executives at AnteoTech.
• • Our database includes 201,469 c suite-level executives.

Salesforce Outlook MailChimp SPF Microsoft Office 365 Stripe reCAPTCHA WordPress.org Facebook Widget Google Tag Manager Mobile Friendly Vimeo Facebook Login (Connect) AI

surface chemistry assay development lithiumion battery development rapid tests anteotech life sciences clean energy technology diagnostic solutions bioconjugation in-vitro diagnostics anteobind anteobind nxt contract services research & development patented technology point-of-care solutions battery performance sustainable growth innovation customized solutions biomolecule binding synthetic substrates solid-phase immunoassays metal-ion complex workflow improvement diagnostic products collaboration customer experience antibody conjugation services lateral flow immunoassays assay design market agility environmental impact iso 9001 certification quality management partnership approach reproducible results electronic vehicles energy storage performance demands cost-effective development customized assays development milestones regulatory compliance research partnerships industry standards antibody savings activated particles microspheres compatibility particle activation bioconjugation chemistry clean energy applications healthcare solutions oil & energy

DR

David Radford Chief Executive Officer and Managing Director at AnteoTech

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

JR

Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

Outreach Guidance — biotechnology Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Manuel Wieser, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

Manuel Wieser's Position in the MessageCEO Database

• •Manuel Wieser is 1 of 2 verified executive contacts we track at AnteoTech.
• •365 verified executive contacts in biotechnology are in the MessageCEO database.
• •6 verified contacts work at biotechnology companies in the 34.0 employee range (same size as AnteoTech).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Manuel Wieser directly?

Manuel Wieser's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at AnteoTech. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Manuel Wieser work for?

Manuel Wieser is Chief Technology Officer at AnteoTech, a company in the biotechnology sector with 34.0 employees.

Can I pitch or sell to Manuel Wieser?

As Chief Technology Officer at AnteoTech, Manuel Wieser is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Manuel Wieser directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Manuel Wieser in?

Manuel Wieser works in the biotechnology industry as Chief Technology Officer at AnteoTech. MessageCEO provides verified contact information for executives across all major industries.

Is Manuel Wieser's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Manuel Wieser's profile is kept up-to-date with the latest available information.

Last updated: June 21, 2026